Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | PPM1B | O75688 | 1/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.50 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.42 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.42 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8631955 | 1.00 | ALDH1A1 (0.53) | ALDH1A1PPM1BPTPN1PPP1CCMEN1 | |
| SCHEMBL453228 | 0.98 | PPM1B (0.51) | ALDH1A1PPM1BPTPN1PPP1CCMEN1 | |
| SCHEMBL29104424 | 0.94 | ALDH1A1 (0.61) | ALDH1A1PPM1BPTPN1PPP1CCMEN1 | |
| SCHEMBL8695709 | 0.94 | PPM1B (0.51) | ALDH1A1PPM1BPTPN1PPP1CCMEN1 | |
| SCHEMBL1245712 | 0.90 | PPM1B (0.45) | ALDH1A1PPM1BPTPN1PPP1CCMEN1 | |
| SCHEMBL526510 | 0.89 | PPM1B (0.55) | ALDH1A1PPM1BPTPN1PPP1CCSMN1; SMN2 | |
| SCHEMBL6141464 | 0.89 | — | — | |
| SCHEMBL482814 | 0.89 | ALDH1A1 (0.47) | ALDH1A1PPM1BPTPN1PPP1CCMEN1 | |
| SCHEMBL10103543 | 0.88 | ALDH1A1 (0.50) | ALDH1A1MEN1KMT2ANAAA | |
| SCHEMBL8633605 | 0.88 | ALDH1A1 (0.50) | ALDH1A1MEN1KMT2ANAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 864 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116023552-B | Catalyst and catalyst system for olefin polymerization | 中国石油化工股份有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-116023553-B | Catalyst component for olefin polymerization reaction, catalyst system and application | 中国石油化工股份有限公司 | 2024-09-17 | — | — | CN | claimed |
| CN-116429932-A | Separation and detection method for liquid crystal and decomposition products in sulfuric acid leaching solution of waste liquid crystal panel | 中国环境科学研究院 | 2023-07-14 | — | — | CN | claimed |
| CN-116023554-A | Catalyst active component, solid catalyst and catalyst system for olefin polymerization | 中国石油化工股份有限公司 | 2023-04-28 | — | — | CN | claimed |
| CN-116023552-A | Catalyst and catalyst system for olefin polymerization | 中国石油化工股份有限公司 | 2023-04-28 | — | — | CN | claimed |
| CN-116023553-A | Catalyst for olefin polymerization reaction, catalyst system and application | 中国石油化工股份有限公司 | 2023-04-28 | — | — | CN | claimed |
| CN-115873155-A | External electron donor composition, propylene polymerization catalytic composition and propylene polymerization method | 湖北华邦化学有限公司 | 2023-03-31 | — | — | CN | claimed |
| CN-114174828-A | Biomarkers for irritable bowel syndrome | 利物浦大学 | 2022-03-11 | — | — | CN | claimed |
| CN-110511539-A | The polymer dispersed liquid crystal layer and preparation method thereof of polyether diamine mixture cured epoxy | HUBEI XIONGHUA TECH CO LTD | 2019-11-29 | — | — | CN | claimed |
| CN-105524192-B | Polypropylene catalyst composition with high temperature active inhibitory action and application thereof | 大唐国际化工技术研究院有限公司 | 2017-11-14 | — | — | CN | claimed |
| US-9427777-B2 | Process for producing charge retention medium | ASAHI GLASS COMPANY, LIMITED (JP) | 2016-08-30 | — | — | US | claimed |
| CN-102471553-B | Fluorine-containing copolymer composition and method for producing same | ASAHI GLASS CO.,LTD. (JP) | 2016-02-10 | — | — | CN | claimed |
| US-20140030609-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND ENERGY STORAGE DEVICE USING SAME | UBE INDUSTRIES, LTD. (JP) | 2014-01-30 | — | — | US | claimed |
| US-20130131032-A1 | NEUROTHERAPEUTIC TREATMENT FOR SEXUAL DYSFUNCTION | REVAAX PHARMACEUTICALS, LLC (US) | 2013-05-23 | — | — | US | claimed |
| CN-101811984-A | Production method of propylcyclohexyl benzonitrile | JIANGSU KANGXIANG GROUP COMPANY | 2010-08-25 | — | — | CN | claimed |
| US-7355040-B2 | Process for the preparation of cephalosporin compounds and synthetic intermediates | ZOETIS SERVICES LLC | 2008-04-08 | — | — | US | claimed |
| US-5491167-A | INHIBITORS OF CHOLESTEROL BIOSYNTHESIS | SANKYO COMPANY, LIMITED (JP) | 1996-02-13 | — | — | US | claimed |
| EP-4508101-B1 | PROCESS FOR MANUFACTURING OF POLYISOBUTENE SUCCINIC ANHYDRIDES | BASF SE (DE) | 2026-03-25 | — | — | EP | disclosed |
| EP-0049071-A1 | N-arylbenzamide derivatives | ELI LILLY AND COMPANY (US) | 1982-04-07 | — | — | EP | disclosed |
| US-4088820-A | Transesterification of olefins | UOP INC. (US) | 1978-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130131032-A1 | NEUROTHERAPEUTIC TREATMENT FOR SEXUAL DYSFUNCTION | PREP, DNPEP, PRSS12 | ALDH1A1 1573/4885PPM1B 3044/4885PTPN1 4540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.